Tag: Lytix

Lytix Biopharma AS – New share capital registered

January 15, 2025

Lytix Biopharma AS – Cancellation of Subsequent Offering

January 7, 2025

Lytix Biopharma AS – New share capital registered

December 24, 2024

Lytix Biopharma AS: Contemplated private placement and retail offer via PrimaryBid

December 17, 2024

Lytix Biopharma – Lytix launches Retail Offering via Primary Bid and Nordnet, in parallel with private placement

December 17, 2024

Lytix Biopharma AS: Private placement and retail offer via PrimaryBid successfully completed

December 16, 2024

Lytix Biopharma – Licensing partner Verrica Pharmaceuticals announces pricing of underwritten public offering, raising approximately USD 42 million upon completion

November 21, 2024

Lytix Biopharma Q3 2024: Positive clinical results and strategic advancements strengthen path to commercialization

November 19, 2024

Lytix Biopharma: Invitation to Q3 2024 Results Presentation

November 12, 2024

First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma

November 6, 2024

Stay Updated

Stay connected with Parenting Bharat for practical advice, inspiring stories, and a supportive community of parents. Let’s grow together in creating the best environment for our children!

Quick Links

Contact Us

Share Your Message!

Copyright© 2025 Parenting Bharat Powered By A Buzz Company